MassMutual Private Wealth & Trust’s Enanta Pharmaceuticals ENTA Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio ENTA Stock Details ENTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-386	Closed	-$2.13K	–	2395
2025 Q1	$2.13K	Buy	+386	New	+$2.38K	﹤0.01%	1895
2023 Q4	–	Sell	-29	Closed	-$324	–	1989
2023 Q3	$324	Buy	+29	New	+$467	﹤0.01%	1881
2022 Q1	–	Sell	-8	Closed	-$1K	–	1555
2021 Q4	$1K	Buy	+8	New	+$628	﹤0.01%	1207

Other funds holding ENTA

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MassMutual Private Wealth & Trust's ENTA Position: Q2 2025 in Review

MassMutual Private Wealth & Trust sold out of Enanta Pharmaceuticals (ENTA) in Q2 2025, closing a stake of 386 shares — an estimated $2.13K sold.

MassMutual Private Wealth & Trust first reported a position in ENTA in Q4 2021 and held it in 3 quarters. The position peaked at $2.13K in Q1 2025. 107 funds tracked by Wall St. Rank hold ENTA as of Q2 2025.

MassMutual Private Wealth & Trust reported no remaining Enanta Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
MassMutual Private Wealth & Trust sold 386 Enanta Pharmaceuticals shares in Q2 2025, an estimated $2.13K.
MassMutual Private Wealth & Trust first reported a position in Enanta Pharmaceuticals in Q4 2021 and held it in 3 quarters.
MassMutual Private Wealth & Trust's Enanta Pharmaceuticals position peaked at $2.13K in Q1 2025.
107 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q2 2025.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2025, filed 9 Jul 2025.